Bio-link Australia Pty. Ltd.

Investment Opportunities

Development of Immuno-Oncology Adjuvant Therapies

An Australian academic alliance of leading biologists, chemists and clinicians from University of Queensland, Children’s Medical Research Institute and the University of Newcastle has generated a compelling data set and intellectual property portfolio focused on an innovative adjuvant strategy for immuno-oncology therapy. It intends to further develop and commercialise this IP portfolio through the formation of a new company.

Summary (PDF)